Vitamin D and its effects on cardiovascular diseases: a comprehensive review |
Perez-Hernandez, Nonanzit
(Department of Molecular Biology, National Institute of Cardiology "Ignacio Chavez")
Aptilon-Duque, Gad (Department of Molecular Biology, National Institute of Cardiology "Ignacio Chavez") Nostroza-Hernandez, Maria Cristina (Department of Molecular Biology, National Institute of Cardiology "Ignacio Chavez") Vargas-Alarcon, Gilberto (Department of Molecular Biology, National Institute of Cardiology "Ignacio Chavez") Rodriguez-Perez, Jose Manuel (Department of Molecular Biology, National Institute of Cardiology "Ignacio Chavez") Blachman-Braun, Ruben (Department of Molecular Biology, National Institute of Cardiology "Ignacio Chavez") |
1 | Boxer RS, Kenny AM, Cheruvu VK, Vest M, Fiutem JJ, Pina II. Serum 25-hydroxyvitamin D concentration is associated with functional capacity in older adults with heart failure. Am Heart J 2010;160:893-899. DOI |
2 | Wannamethee SG, Welsh P, Papacosta O, Lennon L, Whincup PH, Sattar N. Elevated parathyroid hormone, but not vitamin D deficiency, is associated with increased risk of heart failure in older men with and without cardiovascular disease. Circ Heart Fail 2014;7:732-739. DOI |
3 | Petrone AB, Weir NL, Steffen BT, Tsai MY, Gaziano JM, Djousse L. Plasma vitamin D-binding protein and risk of heart failure in male physicians. Am J Cardiol 2013;112:827-830. DOI |
4 | Zoni-Berisso M, Lercari F, Carazza T, Domenicucci S. Epidemiology of atrial fibrillation: European perspective. Clin Epidemiol 2014;6:213-220. |
5 | Balouch MA, Kolek MJ, Darbar D. Improved understanding of the pathophysiology of atrial fibrillation through the lens of discrete pathological pathways. Glob Cardiol Sci Pract 2014;2014:24-36. DOI |
6 | Kessel L. Sick sinus syndrome cured by ... vitamin D? Geriatrics 1990;45:83-85. |
7 | Cardus A, Parisi E, Gallego C, Aldea M, Fernandez E, Valdivielso JM. 1,25-Dihydroxyvitamin D3 stimulates vascular smooth muscle cell proliferation through a VEGF-mediated pathway. Kidney Int 2006;69:1377-1384. DOI |
8 | Demir M, Uyan U, Melek M. The effects of vitamin D deficiency on atrial fibrillation. Clin Appl Thromb Hemost 2014;20:98-103. DOI |
9 | Chen WR, Liu ZY, Shi Y, et al. Relation of low vitamin D to nonvalvular persistent atrial fibrillation in Chinese patients. Ann Noninvasive Electrocardiol 2014;19:166-173. DOI |
10 | Menezes AR, Lavie CJ, DiNicolantonio JJ, et al. Atrial fibrillation in the 21st century: a current understanding of risk factors and primary prevention strategies. Mayo Clin Proc 2013;88:394-409. DOI |
11 | Qayyum F, Landex NL, Agner BR, Rasmussen M, Jons C, Dixen U. Vitamin D deficiency is unrelated to type of atrial fibrillation and its complications. Dan Med J 2012;59:A4505. |
12 | Rienstra M, Cheng S, Larson MG, et al. Vitamin D status is not related to development of atrial fibrillation in the community. Am Heart J 2011;162:538-541. DOI |
13 | Hypponen E, Power C. Vitamin D status and glucose homeostasis in the 1958 British birth cohort: the role of obesity. Diabetes Care 2006;29:2244-2246. DOI |
14 | Prasad P, Kochhar A. Interplay of vitamin D and metabolic syndrome: a review. Diabetes Metab Syndr 2016;10:105-112. DOI |
15 | Pham NM, Akter S, Kurotani K, et al. Serum 25-hydroxyvitamin D and markers of insulin resistance in a Japanese working population. Eur J Clin Nutr 2012;66:1323-1328. DOI |
16 | Heaney RP, French CB, Nguyen S, et al. A novel approach localizes the association of vitamin D status with insulin resistance to one region of the 25-hydroxyvitamin D continuum. Adv Nutr 2013;4:303-310. DOI |
17 | von Hurst PR, Stonehouse W, Coad J. Vitamin D supplementation reduces insulin resistance in South Asian women living in New Zealand who are insulin resistant and vitamin D deficient: a randomised, placebo-controlled trial. Br J Nutr 2010;103:549-555. DOI |
18 | Zhao G, Simpson RU. Membrane localization, caveolin-3 association and rapid actions of vitamin D receptor in cardiac myocytes. Steroids 2010;75(8-9):555-559. DOI |
19 | Wallace IR, Wallace HJ, McKinley MC, Bell PM, Hunter SJ. Vitamin D and insulin resistance. Clin Endocrinol (Oxf) 2015 Mar 2 [Epub]. http://dx.doi.org/10.1111/cen.12760. DOI |
20 | Polly P, Tan TC. The role of vitamin D in skeletal and cardiac muscle function. Front Physiol 2014;5:145. |
21 | Raymond MA, Desormeaux A, Labelle A, et al. Endothelial stress induces the release of vitamin D-binding protein, a novel growth factor. Biochem Biophys Res Commun 2005;338:1374-1382. DOI |
22 | Davignon J, Ganz P. Role of endothelial dysfunction in atherosclerosis. Circulation 2004;109(23 Suppl 1):III27-III32. DOI |
23 | Kunadian V, Ford GA, Bawamia B, Qiu W, Manson JE. Vitamin D deficiency and coronary artery disease: a review of the evidence. Am Heart J 2014;167:283-291. DOI |
24 | Andrukhova O, Slavic S, Zeitz U, et al. Vitamin D is a regulator of endothelial nitric oxide synthase and arterial stiffness in mice. Mol Endocrinol 2014;28:53-64. DOI |
25 | Zittermann A, Schleithoff SS, Koerfer R. Putting cardiovascular disease and vitamin D insufficiency into perspective. Br J Nutr 2005;94:483-492. DOI |
26 | Melamed ML, Muntner P, Michos ED, et al. Serum 25-hydroxyvitamin D levels and the prevalence of peripheral arterial disease: results from NHANES 2001 to 2004. Arterioscler Thromb Vasc Biol 2008;28:1179-1185. DOI |
27 | Ho JS, Cannaday JJ, Barlow CE, Reinhardt DB, Wade WA, Ellis JR. Low 25-OH vitamin D levels are not associated with coronary artery calcium or obstructive stenoses. Coron Artery Dis 2015;26:521-525. DOI |
28 | Shen H, Bielak LF, Ferguson JF, et al. Association of the vitamin D metabolism gene CYP24A1 with coronary artery calcification. Arterioscler Thromb Vasc Biol 2010;30:2648-2654. DOI |
29 | Chua GT, Chan YC, Cheng SW. Vitamin D status and peripheral arterial disease: evidence so far. Vasc Health Risk Manag 2011;7:671-675. |
30 | Chaudhuri JR, Mridula KR, Alladi S, et al. Serum 25-hydroxyvitamin d deficiency in ischemic stroke and subtypes in Indian patients. J Stroke 2014;16:44-50. DOI |
31 | Wang Y, Ji H, Tong Y, Zhang ZB. Prognostic value of serum 25-hydroxyvitamin D in patients with stroke. Neurochem Res 2014;39:1332-1337. DOI |
32 | Elamin MB, Abu Elnour NO, Elamin KB, et al. Vitamin D and cardiovascular outcomes: a systematic review and meta-analysis. J Clin Endocrinol Metab 2011;96:1931-1942. DOI |
33 | Beveridge LA, Struthers AD, Khan F, et al. Effect of vitamin D supplementation on blood pressure: a systematic review and meta-analysis incorporating individual patient data. JAMA Intern Med 2015;175:745-754. DOI |
34 | Demir M, Uyan U, Keceoclu S, Demir C. The relationship between vitamin D deficiency and pulmonary hypertension. Prague Med Rep 2013;114:154-161. DOI |
35 | Pourdjabbar A, Dwivedi G, Haddad H. The role of vitamin D in chronic heart failure. Curr Opin Cardiol 2013;28:216-222. DOI |
36 | Meredith AJ, McManus BM. Vitamin D in heart failure. J Card Fail 2013;19:692-711. DOI |
37 | Choi JH, Ke Q, Bae S, et al. Doxercalciferol, a pro-hormone of vitamin D, prevents the development of cardiac hypertrophy in rats. J Card Fail 2011;17:1051-1058. DOI |
38 | Morris HA. Vitamin D activities for health outcomes. Ann Lab Med 2014;34:181-186. DOI |
39 | Wacker M, Holick MF. Sunlight and vitamin D: a global perspective for health. Dermatoendocrinol 2013;5:51-108. DOI |
40 | Holick MF, Chen TC. Vitamin D deficiency: a worldwide problem with health consequences. Am J Clin Nutr 2008;87:1080S-1086S. DOI |
41 | Parker J, Hashmi O, Dutton D, et al. Levels of vitamin D and cardiometabolic disorders: systematic review and meta-analysis. Maturitas 2010;65:225-236. DOI |
42 | Karur S, Veerappa V, Nanjappa MC. Study of vitamin D deficiency prevalence in acute myocardial infarction. Int J Cardiol Heart Vessels 2014;3:57-59. |
43 | Khalili H, Talasaz AH, Salarifar M. Serum vitamin D concentration status and its correlation with early biomarkers of remodeling following acute myocardial infarction. Clin Res Cardiol 2012;101:321-327. DOI |
44 | Carlson N, Mah R, Aburto M, Peters MJ, Dupper MV, Chen LH. Hypovitaminosis D correction and high-sensitivity C-reactive protein levels in hypertensive adults. Perm J 2013;17:19-21. |
45 | Stach K, Kalsch AI, Nguyen XD, et al. ,25-Dihydroxyvitamin D3 attenuates platelet activation and the expression of VCAM-1 and MT1-MMP in human endothelial cells. Cardiology 2011;118:107-115. DOI |
46 | Lee JH, Gadi R, Spertus JA, Tang F, O'Keefe JH. Prevalence of vitamin D deficiency in patients with acute myocardial infarction. Am J Cardiol 2011;107:1636-1638. DOI |
47 | Moon JY. Recent update of renin-angiotensin-aldosterone system in the pathogenesis of hypertension. Electrolyte Blood Press 2013;11:41-45. DOI |
48 | Basu S, Millett C. Social epidemiology of hypertension in middle-income countries: determinants of prevalence, diagnosis, treatment, and control in the WHO SAGE study. Hypertension 2013;62:18-26. DOI |
49 | Guzman NJ. Epidemiology and management of hypertension in the Hispanic population: a review of the available literature. Am J Cardiovasc Drugs 2012;12:165-178. DOI |
50 | Vongpatanasin W. Resistant hypertension: a review of diagnosis and management. JAMA 2014;311:2216-2224. DOI |
51 | Burgaz A, Orsini N, Larsson SC, Wolk A. Blood 25-hydroxyvitamin D concentration and hypertension: a meta-analysis. J Hypertens 2011;29:636-645. DOI |
52 | Ford JA, MacLennan GS, Avenell A, et al. Cardiovascular disease and vitamin D supplementation: trial analysis, systematic review, and meta-analysis. Am J Clin Nutr 2014;100:746-755. DOI |
53 | Gupta GK, Agrawal T, DelCore MG, Mohiuddin SM, Agrawal DK. Vitamin D deficiency induces cardiac hypertrophy and inflammation in epicardial adipose tissue in hypercholesterolemic swine. Exp Mol Pathol 2012;93:82-90. DOI |
54 | Shedeed SA. Vitamin D supplementation in infants with chronic congestive heart failure. Pediatr Cardiol 2012;33:713-719. DOI |
55 | Schroten NF, Ruifrok WP, Kleijn L, et al. Short-term vitamin D3 supplementation lowers plasma renin activity in patients with stable chronic heart failure: an open-label, blinded end point, randomized prospective trial (VitD-CHF trial). Am Heart J 2013;166:357-364.e2. DOI |
56 | Testa A, Mallamaci F, Benedetto FA, et al. Vitamin D receptor (VDR) gene polymorphism is associated with left ventricular (LV) mass and predicts left ventricular hypertrophy (LVH) progression in end-stage renal disease (ESRD) patients. J Bone Miner Res 2010;25:313-319. DOI |
57 | Greenwood A, Altarescu G, Zimran A, Elstein D. Vitamin D receptor (VDR) polymorphisms in the cardiac variant of Gaucher disease. Pediatr Cardiol 2010;31:30-32. DOI |
58 | Ortlepp JR, Lauscher J, Hoffmann R, Hanrath P, Joost HG. The vitamin D receptor gene variant is associated with the prevalence of type 2 diabetes mellitus and coronary artery disease. Diabet Med 2001;18:842-845. DOI |
59 | Perna L, Felix JF, Breitling LP, et al. Genetic variations in the vitamin D binding protein and season-specific levels of vitamin D among older adults. Epidemiology 2013;24:104-109. DOI |
60 | Liu Z, Liu L, Chen X, He W, Yu X. Associations study of vitamin D receptor gene polymorphisms with diabetic microvascular complications: a meta-analysis. Gene 2014;546:6-10. DOI |
61 | Hong Q, Xu J, Xu S, Lian L, Zhang M, Ding C. Associations between serum 25-hydroxyvitamin D and disease activity, inflammatory cytokines and bone loss in patients with rheumatoid arthritis. Rheumatology (Oxford) 2014;53:1994-2001. DOI |
62 | Pekkanen MP, Ukkola O, Hedberg P, et al. Serum 25-hydroxyvitamin D is associated with major cardiovascular risk factors and cardiac structure and function in patients with coronary artery disease. Nutr Metab Cardiovasc Dis 2015;25:471-478. DOI |
63 | Lappe JM, Travers-Gustafson D, Davies KM, Recker RR, Heaney RP. Vitamin D and calcium supplementation reduces cancer risk: results of a randomized trial. Am J Clin Nutr 2007;85:1586-1591. DOI |
64 | Siasos G, Tousoulis D, Oikonomou E, et al. Vitamin D serum levels are associated with cardiovascular outcome in coronary artery disease. Int J Cardiol 2013;168:4445-4447. DOI |
65 | Jablonski KL, Chonchol M, Pierce GL, Walker AE, Seals DR. 25-Hydroxyvitamin D deficiency is associated with inflammation-linked vascular endothelial dysfunction in middle-aged and older adults. Hypertension 2011;57:63-69. DOI |
66 | Ajabshir S, Asif A, Nayer A. The effects of vitamin D on the renin-angiotensin system. J Nephropathol 2014;3:41-43. |
67 | Tamez H, Kalim S, Thadhani RI. Does vitamin D modulate blood pressure? Curr Opin Nephrol Hypertens 2013;22:204-209. DOI |
68 | Li YC, Kong J, Wei M, Chen ZF, Liu SQ, Cao LP. 1,25-Dihydroxyvitamin D(3) is a negative endocrine regulator of the renin-angiotensin system. J Clin Invest 2002;110:229-238. DOI |
69 | El-Moaty Zaher HA, El-Komy MH, Hegazy RA, Mohamed El Khashab HA, Ahmed HH. Assessment of interleukin-17 and vitamin D serum levels in psoriatic patients. J Am Acad Dermatol 2013;69:840-842. DOI |
70 | Poon AH, Mahboub B, Hamid Q. Vitamin D deficiency and severe asthma. Pharmacol Ther 2013;140:148-155. DOI |
71 | Konikowska K, Regulska-Ilow B. The role of diet in multiple sclerosis. Postepy Hig Med Dosw (Online) 2014;68:325-333. DOI |
72 | Pappa HM, Gordon CM, Saslowsky TM, et al. Vitamin D status in children and young adults with inflammatory bowel disease. Pediatrics 2006;118:1950-1961. DOI |
73 | Belenchia AM, Tosh AK, Hillman LS, Peterson CA. Correcting vitamin D insufficiency improves insulin sensitivity in obese adolescents: a randomized controlled trial. Am J Clin Nutr 2013;97:774-781. DOI |
74 | Pludowski P, Karczmarewicz E, Bayer M, et al. Practical guidelines for the supplementation of vitamin D and the treatment of deficits in Central Europe: recommended vitamin D intakes in the general population and groups at risk of vitamin D deficiency. Endokrynol Pol 2013;64:319-327. DOI |
75 | Razzaque MS. The dualistic role of vitamin D in vascular calcifications. Kidney Int 2011;79:708-714. DOI |
76 | Christakos S, Ajibade DV, Dhawan P, Fechner AJ, Mady LJ. Vitamin D: metabolism. Endocrinol Metab Clin North Am 2010;39:243-253. DOI |
77 | Seker T, Gur M, Kuloglu O, et al. Serum 25-hydroxyvitamin D is associated with both arterial and ventricular stiffness in healthy subjects. J Cardiol 2013;62:361-365. DOI |
78 | Vacek JL, Vanga SR, Good M, Lai SM, Lakkireddy D, Howard PA. Vitamin D deficiency and supplementation and relation to cardiovascular health. Am J Cardiol 2012;109:359-363. DOI |
79 | Webb DR, Khunti K, Lacy P, et al. Conduit vessel stiffness in British south Asians of Indian descent relates to 25-hydroxyvitamin D status. J Hypertens 2012;30:1588-1596. DOI |
80 | Brewer LC, Michos ED, Reis JP. Vitamin D in atherosclerosis, vascular disease, and endothelial function. Curr Drug Targets 2011;12:54-60. DOI |
81 | Al Mheid I, Patel R, Murrow J, et al. Vitamin D status is associated with arterial stiffness and vascular dysfunction in healthy humans. J Am Coll Cardiol 2011;58:186-192. DOI |
82 | Syal SK, Kapoor A, Bhatia E, et al. Vitamin D deficiency, coronary artery disease, and endothelial dysfunction: observations from a coronary angiographic study in Indian patients. J Invasive Cardiol 2012;24:385-389. |
83 | Chen WR, Qian YA, Chen YD, et al. The effects of low vitamin D on coronary artery disease. Heart Lung Circ 2014;23:314-319. DOI |
84 | Joergensen C, Reinhard H, Schmedes A, et al. Vitamin D levels and asymptomatic coronary artery disease in type 2 diabetic patients with elevated urinary albumin excretion rate. Diabetes Care 2012;35:168-172. DOI |
85 | Wong MS, Delansorne R, Man RY, Svenningsen P, Vanhoutte PM. Chronic treatment with vitamin D lowers arterial blood pressure and reduces endothelium-dependent contractions in the aorta of the spontaneously hypertensive rat. Am J Physiol Heart Circ Physiol 2010;299:H1226-H1234. DOI |
86 | Zhou C, Lu F, Cao K, Xu D, Goltzman D, Miao D. Calcium-independent and 1,25(OH)2D3-dependent regulation of the renin-angiotensin system in 1alpha-hydroxylase knockout mice. Kidney Int 2008;74:170-179. DOI |
87 | Weng S, Sprague JE, Oh J, et al. Vitamin D deficiency induces high blood pressure and accelerates atherosclerosis in mice. PLoS One 2013;8:e54625. DOI |
88 | Tare M, Emmett SJ, Coleman HA, et al. Vitamin D insufficiency is associated with impaired vascular endothelial and smooth muscle function and hypertension in young rats. J Physiol 2011;589(Pt 19):4777-4786. DOI |
89 | Min B. Effects of vitamin D on blood pressure and endothelial function. Korean J Physiol Pharmacol 2013;17:385-392. DOI |
90 | Rostand SG. Vitamin D, blood pressure, and African Americans: toward a unifying hypothesis. Clin J Am Soc Nephrol 2010;5:1697-1703. DOI |
91 | Scragg R, Sowers M, Bell C. Serum 25-hydroxyvitamin D, ethnicity, and blood pressure in the Third National Health and Nutrition Examination Survey. Am J Hypertens 2007;20:713-719. DOI |
92 | Holick MF. Vitamin D deficiency. N Engl J Med 2007;357:266-281. DOI |
93 | Campbell MJ. Vitamin D and the RNA transcriptome: more than mRNA regulation. Front Physiol 2014;5:181. |
94 | Wong MS, Leisegang MS, Kruse C, et al. Vitamin D promotes vascular regeneration. Circulation 2014;130:976-986. DOI |
95 | Wang TJ, Pencina MJ, Booth SL, et al. Vitamin D deficiency and risk of cardiovascular disease. Circulation 2008;117:503-511. DOI |
96 | Looker AC, Johnson CL, Lacher DA, Pfeiffer CM, Schleicher RL, Sempos CT. Vitamin D status: United States, 2001-2006. NCHS Data Brief 2011;(59):1-8. |
97 | Lavie CJ, Lee JH, Milani RV. Vitamin D and cardiovascular disease will it live up to its hype? J Am Coll Cardiol 2011;58:1547-1556. DOI |
98 | Ross AC, Manson JE, Abrams SA, et al. The 2011 report on dietary reference intakes for calcium and vitamin D from the Institute of Medicine: what clinicians need to know. J Clin Endocrinol Metab 2011;96:53-58. DOI |
99 | Holick MF, Binkley NC, Bischoff-Ferrari HA, et al. Evaluation, treatment, and prevention of vitamin D deficiency: an Endocrine Society clinical practice guideline. J Clin Endocrinol Metab 2011;96:1911-1930. DOI |
100 | Wortsman J, Matsuoka LY, Chen TC, Lu Z, Holick MF. Decreased bioavailability of vitamin D in obesity. Am J Clin Nutr 2000;72:690-693. DOI |
101 | Shroff R, Egerton M, Bridel M, et al. A bimodal association of vitamin D levels and vascular disease in children on dialysis. J Am Soc Nephrol 2008;19:1239-1246. DOI |
102 | Lai H, Gerstenblith G, Fishman EK, et al. Vitamin D deficiency is associated with silent coronary artery disease in cardiovascularly asymptomatic African Americans with HIV infection. Clin Infect Dis 2012;54:1747-1755. DOI |
103 | Hsu JJ, Tintut Y, Demer LL. Vitamin D and osteogenic differentiation in the artery wall. Clin J Am Soc Nephrol 2008;3:1542-1547. DOI |
104 | Liberman M, Pesaro AE, Carmo LS, Serrano Jr CV. Vascular calcification: pathophysiology and clinical implications. Einstein (Sao Paulo) 2013;11:376-382. DOI |
105 | Krasniak A, Drozdz M, Pasowicz M, et al. Factors involved in vascular calcification and atherosclerosis in maintenance haemodialysis patients. Nephrol Dial Transplant 2007;22:515-521. |
106 | Schmidt N, Brandsch C, Schutkowski A, Hirche F, Stangl GI. Dietary vitamin D inadequacy accelerates calcification and osteoblast-like cell formation in the vascular system of LDL receptor knockout and wild-type mice. J Nutr 2014;144:638-646. DOI |
107 | Zebger-Gong H, Muller D, Diercke M, et al. 1,25-Dihydroxyvitamin D3-induced aortic calcifications in experimental uremia: up-regulation of osteoblast markers, calcium-transporting proteins and osterix. J Hypertens 2011;29:339-348. DOI |
108 | Rostand SG. Ultraviolet light may contribute to geographic and racial blood pressure differences. Hypertension 1997;30(2 Pt 1):150-156. DOI |
109 | Hintzpeter B, Mensink GB, Thierfelder W, Muller MJ, Scheidt-Nave C. Vitamin D status and health correlates among German adults. Eur J Clin Nutr 2008;62:1079-1089. DOI |
110 | Fares A. Winter hypertension: potential mechanisms. Int J Health Sci (Qassim) 2013;7:210-219. DOI |
111 | Forman JP, Williams JS, Fisher ND. Plasma 25-hydroxyvitamin D and regulation of the renin-angiotensin system in humans. Hypertension 2010;55:1283-1288. DOI |
112 | Nasri H, Behradmanesh S, Ahmadi A, Rafieian-Kopaei M. Impact of oral vitamin D (cholecalciferol) replacement therapy on blood pressure in type 2 diabetes patients: a randomized, double-blind, placebo controlled clinical trial. J Nephropathol 2014;3:29-33. |
113 | Larsen T, Mose FH, Bech JN, Hansen AB, Pedersen EB. Effect of cholecalciferol supplementation during winter months in patients with hypertension: a randomized, placebo-controlled trial. Am J Hypertens 2012;25:1215-1222. DOI |
114 | Forman JP, Scott JB, Ng K, et al. Effect of vitamin D supplementation on blood pressure in blacks. Hypertension 2013;61:779-785. DOI |
115 | Judd SE, Raiser SN, Kumari M, Tangpricha V. 1,25-Dihydroxyvitamin D3 reduces systolic blood pressure in hypertensive adults: a pilot feasibility study. J Steroid Biochem Mol Biol 2010;121(1-2):445-447. DOI |
116 | Malik R, Aneni EC, Roberson L, et al. Measuring coronary artery calcification: is serum vitamin D relevant? Atherosclerosis 2014;237:734-738. DOI |
117 | Bidgoli SA, Azarshab H. Role of vitamin D deficiency and lack of sun exposure in the incidence of premenopausal breast cancer: a case control study in Sabzevar, Iran. Asian Pac J Cancer Prev 2014;15:3391-3396. DOI |
118 | Cipriani C, Pepe J, Piemonte S, Colangelo L, Cilli M, Minisola S. Vitamin D and its relationship with obesity and muscle. Int J Endocrinol 2014;2014:841248. |
119 | Libby P, Theroux P. Pathophysiology of coronary artery disease. Circulation 2005;111:3481-3488. DOI |
120 | Ding Y, Liao W, Yi Z, Xiang W, He X. Cardioprotective role of vitamin D receptor in circulating endothelial cells of ApoE-deficient mice. Int J Clin Exp Med 2015;8:5065-5074. |
121 | Witham MD, Price RJ, Struthers AD, et al. Cholecalciferol treatment to reduce blood pressure in older patients with isolated systolic hypertension: the VitDISH randomized controlled trial. JAMA Intern Med 2013;173:1672-1679. |
122 | Witham MD, Nadir MA, Struthers AD. Effect of vitamin D on blood pressure: a systematic review and meta-analysis. J Hypertens 2009;27:1948-1954. DOI |